{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:43:55Z","timestamp":1787021035643,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fresnius Kabi"},{"name":"Ontario Medical Supply Inc"},{"name":"Chulalongkorn University and King Chulalongkorn Memorial Hospital, The Thai Red Cross Society"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pilot Feasibility Stud"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Home parenteral nutrition (HPN) can be associated with increased liver enzymes, catheter-related bloodstream infections (CRBSI), and hospitalizations. Mixed oil (MO) versus soybean oil (SO) lipid emulsion reduces risks in hospitalized patients, but there are no randomized double-blinded controlled trials in HPN. Therefore, the primary objective was to test the study\u2019s feasibility such as recruitment and retention in the HPN population and the secondary objective was to assess changes in liver enzymes between MO and SO as well as other clinical and biochemical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This 13-month prospective double-blind crossover randomized pilot trial took place in Toronto, Canada. Participants were HPN patients who were a part of the HPN program at Toronto General Hospital. We recruited patients from the HPN program. HPN patients receiving SO were randomized to either MO or SO, and the study duration was 6\u00a0months in each arm (MO or SO) with a 1-month washout period resuming SO. As this is a crossover trial design, the patient is his\/her own control. The main outcome measures were descriptions of study feasibility, namely the study recruitment and retention. We also collected biochemical parameters, CRSBI, hospitalization rate, antibiotic use, and mortality. Demographic, nutritional, clinical, and laboratory data were collected at baseline, 3 and 6\u00a0months of each arm. The primary analysis population was defined as the per-protocol population who completed the trial including all lipid measurements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 65 HPN patients were assessed, and 60 met the inclusion criteria for the study. Thirty-five percent (21\/60) were randomized using a computer-generated random number sequence generator: 10 participants were randomized to receive SO first while 11 were randomized to receive MO first. At 13\u00a0months, 3\/10 who received SO first completed the study, whereas 9\/11 who received MO first completed the study. This did not meet our a priori criteria for success in recruitment and retention. Between types of lipid emulsions, there were no significant differences in changes in liver enzymes or biochemical and clinical outcomes, despite significant changes in plasma free fatty acid composition reflecting MO or SO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, this pilot trial demonstrated that the use of a prospective double-blind, crossover, randomized trial design was not feasible to conduct in the HPN population because of difficulties in recruiting and retaining patients. In addition, there was no significant impact of MO versus SO lipid emulsion on liver enzymes or most parameters. The lack of significance may be attributed to low sample size from low recruitment and high drop-out rate, short study duration (6\u00a0months\/arm), and complex care. In a future definitive trial, a multicenter study of longer duration and a larger sample size is recommended, and drop-outs may be reduced by using a parallel study design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, NCT02796833. Registered on 13 June 2016\u2014retrospectively registered.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40814-023-01295-1","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T13:27:27Z","timestamp":1681997247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparing mixed oil to soybean oil lipid emulsion in patients on home parenteral nutrition: a pilot prospective double-blind, crossover, randomized trial"],"prefix":"10.1186","volume":"9","author":[{"given":"Nayima M.","family":"Clermont-Dejean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine J. P.","family":"Schwenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Arca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicha","family":"Somlaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amnah","family":"Alhanaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta\u00eds Daiene Russo","family":"Hortencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyejung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8956-7059","authenticated-orcid":false,"given":"Johane P.","family":"Allard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"key":"1295_CR1","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.clnu.2020.03.005","volume":"39","author":"L Pironi","year":"2020","unstructured":"Pironi L, Boeykens K, Bozzetti F, Joly F, Klek S, Lal S, et al. ESPEN guideline on home parenteral nutrition. Clin Nutr. 2020;39:1645\u201366.","journal-title":"Clin Nutr"},{"key":"1295_CR2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.clnu.2016.12.026","volume":"37","author":"CJ Jones","year":"2018","unstructured":"Jones CJ, Calder PC. Influence of different intravenous lipid emulsions on fatty acid status and laboratory and clinical outcomes in adult patients receiving home parenteral nutrition: a systematic review. Clin Nutr. 2018;37:285\u201391.","journal-title":"Clin Nutr"},{"issue":"Suppl 1","key":"1295_CR3","first-page":"S21","volume":"44","author":"PC Calder","year":"2020","unstructured":"Calder PC, Waitzberg DL, Klek S, Martindale RG. Lipids in parenteral nutrition: biological aspects. JPEN J Parenter Enteral Nutr. 2020;44(Suppl 1):S21\u20137.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"1295_CR4","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/ajcn\/85.5.1171","volume":"85","author":"GJ Wanten","year":"2007","unstructured":"Wanten GJ, Calder PC. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr. 2007;85:1171\u201384.","journal-title":"Am J Clin Nutr"},{"issue":"Suppl 1","key":"1295_CR5","first-page":"S39","volume":"44","author":"MS Mundi","year":"2020","unstructured":"Mundi MS, Klek S, Martindale RG. Use of lipids in adult patients requiring parenteral nutrition in the home setting. JPEN J Parenter Enteral Nutr. 2020;44(Suppl 1):S39\u201344.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"1295_CR6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0884533616663635","volume":"31","author":"MS Mundi","year":"2016","unstructured":"Mundi MS, Salonen BR, Bonnes S. Home parenteral nutrition: fat emulsions and potential complications. Nutr Clin Pract. 2016;31:629\u201341.","journal-title":"Nutr Clin Pract"},{"key":"1295_CR7","doi-asserted-by":"publisher","unstructured":"Klek S. Omega-3 fatty acids in modern parenteral nutrition: a review of the current evidence. J Clin Med. 2016;5(3):34. https:\/\/doi.org\/10.3390\/jcm5030034.","DOI":"10.3390\/jcm5030034"},{"key":"1295_CR8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/MOT.0b013e3283394879","volume":"15","author":"EM Fallon","year":"2010","unstructured":"Fallon EM, Le HD, Puder M. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil. Curr Opin Organ Transplant. 2010;15:334\u201340.","journal-title":"Curr Opin Organ Transplant"},{"key":"1295_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/MOT.0000000000000620","volume":"24","author":"J Lim","year":"2019","unstructured":"Lim J, Oschman A, Curiel K. Current status of lipid emulsions in the prevention of intestinal failure-associated liver disease. Curr Opin Organ Transplant. 2019;24:188\u201392.","journal-title":"Curr Opin Organ Transplant"},{"key":"1295_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.nutres.2019.10.004","volume":"72","author":"F Novak","year":"2019","unstructured":"Novak F, Vecka M, Meisnerova E, Sevela S, Vavrova L, Rychlikova J, et al. Fish oil supplementation with various lipid emulsions suppresses in vitro cytokine release in home parenteral nutrition patients: a crossover study. Nutr Res. 2019;72:70\u20139.","journal-title":"Nutr Res"},{"key":"1295_CR11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.clnu.2012.06.011","volume":"32","author":"S Klek","year":"2013","unstructured":"Klek S, Chambrier C, Singer P, Rubin M, Bowling T, Staun M, et al. Four-week parenteral nutrition using a third generation lipid emulsion (SMOFlipid)\u2013a double-blind, randomised, multicentre study in adults. Clin Nutr. 2013;32:224\u201331.","journal-title":"Clin Nutr"},{"key":"1295_CR12","first-page":"6301293","volume":"2018","author":"AA Leguina-Ruzzi","year":"2018","unstructured":"Leguina-Ruzzi AA, Ortiz R. Current evidence for the use of Smoflipid(R) emulsion in critical care patients for parenteral nutrition. Crit Care Res Pract. 2018;2018:6301293.","journal-title":"Crit Care Res Pract"},{"issue":"Suppl 1","key":"1295_CR13","first-page":"S28","volume":"44","author":"K Mayer","year":"2020","unstructured":"Mayer K, Klek S, Garcia-de-Lorenzo A, Rosenthal MD, Li A, Evans DC, et al. Lipid use in hospitalized adults requiring parenteral nutrition. JPEN J Parenter Enteral Nutr. 2020;44(Suppl 1):S28\u201338.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"1295_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jpen.1526","volume":"44","author":"MS Mundi","year":"2020","unstructured":"Mundi MS, Kuchkuntla AR, Salonen BR, Bonnes S, Hurt RT. Long-term use of mixed-oil lipid emulsion in soybean oil-intolerant home parenteral nutrition patients. JPEN J Parenter Enteral Nutr. 2020;44:301\u20137.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"1295_CR15","doi-asserted-by":"publisher","unstructured":"Pradelli L, Klek S, Mayer K, Omar Alsaleh AJ, Rosenthal MD, Heller AR, Muscaritoli M. Cost-effectiveness of parenteral nutrition containing \u03c9-3 fatty acids in hospitalized adult patients from 5 European countries and the US. JPEN J Parenter Enteral Nutr. 2021;45(5):999\u20131008. https:\/\/doi.org\/10.1002\/jpen.1972.","DOI":"10.1002\/jpen.1972"},{"key":"1295_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/jpen.1672","volume":"44","author":"L Pradelli","year":"2020","unstructured":"Pradelli L, Mayer K, Klek S, Omar Alsaleh AJ, Clark RAC, Rosenthal MD, et al. omega-3 fatty-acid enriched parenteral nutrition in hospitalized patients: systematic review with meta-analysis and trial sequential analysis. JPEN J Parenter Enteral Nutr. 2020;44:44\u201357.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"1295_CR17","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/nure.12053","volume":"71","author":"H Tian","year":"2013","unstructured":"Tian H, Yao X, Zeng R, Sun R, Tian H, Shi C, et al. Safety and efficacy of a new parenteral lipid emulsion (SMOF) for surgical patients: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2013;71:815\u201321.","journal-title":"Nutr Rev"},{"key":"1295_CR18","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/MPG.0b013e3181de210c","volume":"51","author":"E Tomsits","year":"2010","unstructured":"Tomsits E, Pataki M, Tolgyesi A, Fekete G, Rischak K, Szollar L. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr. 2010;51:514\u201321.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1295_CR19","doi-asserted-by":"publisher","first-page":"904","DOI":"10.2146\/ajhp151015","volume":"74","author":"HJ Bae","year":"2017","unstructured":"Bae HJ, Lee GY, Seong JM, Gwak HS. Outcomes with perioperative fat emulsions containing omega-3 fatty acid: a meta-analysis of randomized controlled trials. Am J Health Syst Pharm. 2017;74:904\u201318.","journal-title":"Am J Health Syst Pharm"},{"key":"1295_CR20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2147\/CEOR.S139902","volume":"9","author":"Y Feng","year":"2017","unstructured":"Feng Y, Li C, Zhang T, Pradelli L. Parenteral nutrition including an omega-3 fatty-acid-containing lipid emulsion for intensive care patients in China: a pharmacoeconomic analysis. Clinicoecon Outcomes Res. 2017;9:547\u201355.","journal-title":"Clinicoecon Outcomes Res"},{"key":"1295_CR21","doi-asserted-by":"publisher","first-page":"17S","DOI":"10.1177\/0148607117741870","volume":"41","author":"RT Hurt","year":"2017","unstructured":"Hurt RT, Mundi MS. Use of mixed-oil fat emulsion to improve intestinal failure-associated liver disease in long-term home parenteral nutrition: a case report. JPEN J Parenter Enteral Nutr. 2017;41:17S-S19.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"1295_CR22","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1155\/2007\/217897","volume":"21","author":"M Raman","year":"2007","unstructured":"Raman M, Gramlich L, Whittaker S, Allard JP. Canadian home total parenteral nutrition registry: preliminary data on the patient population. Can J Gastroenterol. 2007;21:643\u20138.","journal-title":"Can J Gastroenterol"},{"key":"1295_CR23","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.clnu.2018.05.028","volume":"38","author":"S Osowska","year":"2019","unstructured":"Osowska S, Kunecki M, Sobocki J, Tokarczyk J, Majewska K, Omidi M, et al. Effect of changing the lipid component of home parenteral nutrition in adults. Clin Nutr. 2019;38:1355\u201361.","journal-title":"Clin Nutr"},{"key":"1295_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.clnu.2014.08.017","volume":"34","author":"L Pironi","year":"2015","unstructured":"Pironi L, Arends J, Baxter J, Bozzetti F, Pelaez RB, Cuerda C, et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutr. 2015;34:171\u201380.","journal-title":"Clin Nutr."},{"key":"1295_CR25","doi-asserted-by":"publisher","unstructured":"Klek S, Szczepanek K, Scislo L, Walewska E, Pietka M, Pisarska M, Pedziwiatr M. Intravenous lipid emulsions and liver function in adult chronic intestinal failure patients: results after 5 y of home parenteral nutrition. Nutrition. 2021;82:111029. ISSN 0899-9007. https:\/\/doi.org\/10.1016\/j.nut.2020.111029, https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0899900720303129.","DOI":"10.1016\/j.nut.2020.111029"},{"key":"1295_CR26","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1016\/j.clnu.2021.06.012","volume":"40","author":"NM Clermont-Dejean","year":"2021","unstructured":"Clermont-Dejean NM, Schwenger KJP, Salazar E, Colombo FF, Lu Z, Lou W, et al. Home parenteral nutrition patients on mixed oil lipid emulsion have a higher rate of hospitalizations compare to those on soybean oil- a prospective 2-year cohort study. Clin Nutr. 2021;40:4616\u201323.","journal-title":"Clin Nutr"},{"key":"1295_CR27","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497\u2013509.","journal-title":"J Biol Chem"},{"key":"1295_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2021.111283","volume":"89","author":"E Salazar","year":"2021","unstructured":"Salazar E, Alenezi S, Schwenger KJP, Casselman S, Somlaw N, Kim P, et al. Olive oil-based lipid emulsion is noninferior to soybean oil-based lipid emulsion in the acute care setting: A double-blind randomized controlled trial. Nutrition. 2021;89: 111283.","journal-title":"Nutrition"},{"key":"1295_CR29","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1017\/S0029665113001031","volume":"72","author":"PC Calder","year":"2013","unstructured":"Calder PC. n-3 fatty acids, inflammation and immunity: new mechanisms to explain old actions. Proc Nutr Soc. 2013;72:326\u201336.","journal-title":"Proc Nutr Soc"},{"key":"1295_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.plipres.2016.07.002","volume":"64","author":"EJ Baker","year":"2016","unstructured":"Baker EJ, Miles EA, Burdge GC, Yaqoob P, Calder PC. Metabolism and functional effects of plant-derived omega-3 fatty acids in humans. Prog Lipid Res. 2016;64:30\u201356.","journal-title":"Prog Lipid Res"},{"key":"1295_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.plefa.2018.03.004","volume":"132","author":"JK Innes","year":"2018","unstructured":"Innes JK, Calder PC. Omega-6 fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids. 2018;132:41\u20138.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"1295_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/flgastro-2018-101094","volume":"11","author":"A Bond","year":"2020","unstructured":"Bond A, Chadwick P, Smith TR, Nightingale JMD, Lal S. Diagnosis and management of catheter-related bloodstream infections in patients on home parenteral nutrition. Frontline Gastroenterol. 2020;11:48\u201354.","journal-title":"Frontline Gastroenterol"},{"key":"1295_CR33","volume-title":"M Practical Biostatistics","author":"MG Suchmacher","year":"2012","unstructured":"Suchmacher MG. M Practical Biostatistics. 2012."},{"key":"1295_CR34","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1186\/s13063-019-3994-z","volume":"20","author":"S Klek","year":"2019","unstructured":"Klek S, Chambrier C, Cooper SC, Gabe S, Kunecki M, Pironi L, et al. Home parenteral nutrition with an omega-3-fatty-acid-enriched MCT\/LCT lipid emulsion in patients with chronic intestinal failure (the HOME study): study protocol for a randomized, controlled, multicenter, international clinical trial. Trials. 2019;20:808.","journal-title":"Trials"},{"key":"1295_CR35","doi-asserted-by":"publisher","first-page":"525","DOI":"10.7326\/0003-4819-132-7-200004040-00003","volume":"132","author":"M Cavicchi","year":"2000","unstructured":"Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000;132:525\u201332.","journal-title":"Ann Intern Med"},{"key":"1295_CR36","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/ejcn.2014.118","volume":"68","author":"J Pichler","year":"2014","unstructured":"Pichler J, Simchowitz V, Macdonald S, Hill S. Comparison of liver function with two new\/mixed intravenous lipid emulsions in children with intestinal failure. Eur J Clin Nutr. 2014;68:1161\u20137.","journal-title":"Eur J Clin Nutr"},{"key":"1295_CR37","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/jpen.1692","volume":"44","author":"C Belza","year":"2020","unstructured":"Belza C, Wales JC, Courtney-Martin G, de Silva N, Avitzur Y, Wales PW. An observational study of smoflipid vs intralipid on the evolution of intestinal failure-associated liver disease in infants with intestinal failure. JPEN J Parenter Enteral Nutr. 2020;44:688\u201396.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"1295_CR38","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/jpen.1929","volume":"45","author":"KA Huff","year":"2021","unstructured":"Huff KA, Breckler F, Cruse W, Szeszycki E, Vanderpool C. Pediatric smoflipid therapy: patient response and safety concerns. JPEN J Parenter Enteral Nutr. 2021;45:792\u20139.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"1295_CR39","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1177\/0148607111434599","volume":"36","author":"G Fernandes","year":"2012","unstructured":"Fernandes G, Kaila B, Jeejeebhoy KN, Gramlich L, Armstrong D, Allard JP. Canadian home parenteral nutrition (HPN) registry: validation and patient outcomes. JPEN J Parenter Enteral Nutr. 2012;36:407\u201314.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"1295_CR40","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/jpen.1866","volume":"45","author":"E Salazar","year":"2021","unstructured":"Salazar E, Clermont-Dejean NM, Schwenger KJP, Noelting J, Lu Z, Lou W, et al. Patients with severe gastrointestinal dysmotility disorders receiving home parenteral nutrition have similar survival as those with short-bowel syndrome: a prospective cohort study. JPEN J Parenter Enteral Nutr. 2021;45:530\u20137.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"1295_CR41","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/jpen.1984","volume":"45","author":"J Noelting","year":"2021","unstructured":"Noelting J, Gramlich L, Whittaker S, Armstrong D, Marliss E, Jurewitsch B, et al. Survival of patients with short-bowel syndrome on home parenteral nutrition: a prospective cohort study. JPEN J Parenter Enteral Nutr. 2021;45:1083\u20138.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"1295_CR42","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hep.29085","volume":"65","author":"PS Dulai","year":"2017","unstructured":"Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis. Hepatology. 2017;65:1557\u201365.","journal-title":"Hepatology"}],"container-title":["Pilot and Feasibility Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-023-01295-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40814-023-01295-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-023-01295-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T13:32:28Z","timestamp":1681997548000},"score":1,"resource":{"primary":{"URL":"https:\/\/pilotfeasibilitystudies.biomedcentral.com\/articles\/10.1186\/s40814-023-01295-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1295"],"URL":"https:\/\/doi.org\/10.1186\/s40814-023-01295-1","relation":{},"ISSN":["2055-5784"],"issn-type":[{"value":"2055-5784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,20]]},"assertion":[{"value":"1 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}